Literature DB >> 34205807

Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach.

Elisabet Rodríguez-Tomàs1, Simona Iftimie2, Helena Castañé1, Gerard Baiges-Gaya1, Anna Hernández-Aguilera1, María González-Viñas2, Antoni Castro2, Jordi Camps1, Jorge Joven1.   

Abstract

SARS-CoV-2 infection produces a response of the innate immune system causing oxidative stress and a strong inflammatory reaction termed 'cytokine storm' that is one of the leading causes of death. Paraoxonase-1 (PON1) protects against oxidative stress by hydrolyzing lipoperoxides. Alterations in PON1 activity have been associated with pro-inflammatory mediators such as the chemokine (C-C motif) ligand 2 (CCL2), and the glycoprotein galectin-3. We aimed to investigate the alterations in the circulating levels of PON1, CCL2, and galectin-3 in 126 patients with COVID-19 and their interactions with clinical variables and analytical parameters. A machine learning approach was used to identify predictive markers of the disease. For comparisons, we recruited 45 COVID-19 negative patients and 50 healthy individuals. Our approach identified a synergy between oxidative stress, inflammation, and fibrogenesis in positive patients that is not observed in negative patients. PON1 activity was the parameter with the greatest power to discriminate between patients who were either positive or negative for COVID-19, while their levels of CCL2 and galectin-3 were similar. We suggest that the measurement of serum PON1 activity may be a useful marker for the diagnosis of COVID-19.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; biomarkers; chemokines; galectin-3; machine learning; paraoxonase-1

Year:  2021        PMID: 34205807     DOI: 10.3390/antiox10060991

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  6 in total

1.  Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia.

Authors:  Elisabet Rodríguez-Tomàs; Johana C Acosta; Laura Torres-Royo; Gabriel De Febrer; Gerard Baiges-Gaya; Helena Castañé; Andrea Jiménez; Carlos Vasco; Pablo Araguas; Junior Gómez; Bárbara Malave; Miguel Árquez; David Calderón; Berta Piqué; Manel Algara; Ángel Montero; Josep M Simó; Xavier Gabaldó-Barrios; Sebastià Sabater; Jordi Camps; Jorge Joven; Meritxell Arenas
Journal:  Antioxidants (Basel)       Date:  2022-06-16

2.  Paraoxonase-1 Facilitates PRRSV Replication by Interacting with Viral Nonstructural Protein-9 and Inhibiting Type I Interferon Pathway.

Authors:  Lin Zhang; Yu Pan; Yunfei Xu; Wenli Zhang; Wenjie Ma; Yassein M Ibrahim; Gebremeskel Mamu Werid; He Zhang; Changyou Xia; Ping Wei; Hongyan Chen; Yue Wang
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

3.  Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients.

Authors:  Helena Castañé; Simona Iftimie; Gerard Baiges-Gaya; Elisabet Rodríguez-Tomàs; Andrea Jiménez-Franco; Ana Felisa López-Azcona; Pedro Garrido; Antoni Castro; Jordi Camps; Jorge Joven
Journal:  Metabolism       Date:  2022-04-02       Impact factor: 13.934

4.  Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19.

Authors:  Xavier Gabaldó; Màrius Juanpere; Helena Castañé; Elisabet Rodríguez-Tomàs; Ana Felisa López-Azcona; Gerard Baiges-Gaya; Lourdes Castro; Enrique Valverde-Díaz; Aida Muñoz-Blázquez; Laura Giménez-Cuenca; Laura Felipo-Balada; Frederic Ballester; Isabel Pujol; Josep M Simó; Antoni Castro; Simona Iftimie; Jordi Camps; Jorge Joven
Journal:  Biomolecules       Date:  2022-06-23

Review 5.  Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review.

Authors:  Evangelia Eirini Tsermpini; Una Glamočlija; Fulden Ulucan-Karnak; Sara Redenšek Trampuž; Vita Dolžan
Journal:  Antioxidants (Basel)       Date:  2022-08-19

6.  HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study.

Authors:  Bianca Papotti; Chiara Macchi; Chiara Favero; Simona Iodice; Maria Pia Adorni; Francesca Zimetti; Alberto Corsini; Stefano Aliberti; Francesco Blasi; Stefano Carugo; Valentina Bollati; Marco Vicenzi; Massimiliano Ruscica
Journal:  J Clin Med       Date:  2021-12-18       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.